Website banner for other pages3

ICBI Companies

Current Companies

Anagin Logo

Anagin

Developing new therapies for pain and traumatic brain injury.

Ciconia

Ciconia Biosciences, a preclinical Partner Research Organization (PtRO), is dedicated to expediting the discovery of next generation therapies for diverse health disorders.
Degrome Therapeutics

Degrome Theraputics

Degrome Therapeutics, Inc. is specialized in discovery and development of small molecule degraders of neurodegenerative disease-causing proteins as the first-in-class drugs. The company was founded by Drs. Anita Bellail and Chunhai Hao in 2023 in Indiana after they identified hit compounds as Alzheimer Precursor Protein (APP) degrader.

E & E BioClub

E&E BioClub focuses on facilitating the advancement of biotherapeutics into the clinical stage by developing cost-effective and scalable manufacturing processes.
General Optics Logo

General Optics

Research and Development in Optical Devices, Medical Imaging and Nanofabrication.
HB Theraputics Logo

HB Therapeutics

Discovery and development of small molecule protein degraders as new anticancer drugs.
Health Smart Logo

Health Smart Technologies

Health Smart Technologies, Inc. is an Indiana University based company that merges Engineering and Rehabilitation expertise to develop Smart technology advancing manual therapy.
Monon Bioventures Logo

Monon Bioventures

Assisting world-class investigators to navigate the early stage challenges of translating their research into the clinic.
Scioto Biosciences logo

Scioto Biosciences

Developing innovative therapies devoted to having a significant impact on the delivery of microbiome therapeutics.
Simmaron Logo

Simmaron Research

Simmaron Research is working to improve the diagnosis, treatment and medical understanding of Myalgic Encephalomyelitis/Chronic Fatigue Syndrome (ME/CFS) and other neuroimmune diseases.
Vasculonics Logo

Vasculonics

Treatment of vascular complications.

Graduated Companies


Femtera

Leading discovery & clinical diagnostic applications of novel metabolite biomarkers for the detection of catastrophic diseases.

Genezen

Offers contract viral vector production, transduced cell manufacturing, and clinical trial testing services by leveraging the expertise of the nation’s leading academic vector production and research laboratories.
Early is good logo

Early is Good

Co-Founded by Dr. Thakshila Liyanage and Asel Liyanage, Early is Good is a cancer diagnostic company taking aim at first creating a simple urine test (BCDx – biomarker detection) for bladder cancer.